Two Sigma Investments’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Other funds holding BCDA
CM
VCM
VFT
PP
XT
VF
Two Sigma Investments's BCDA Position: Q1 2026 in Review
Two Sigma Investments sold out of BioCardia (BCDA) in Q1 2026, closing a stake of 11,229 shares — an estimated $14K sold.
Two Sigma Investments first reported a position in BCDA in Q4 2025 and held it in 1 quarter. The position peaked at $14K in Q4 2025. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.
- Two Sigma Investments reported no remaining BioCardia position as of Q1 2026 after selling out during the quarter.
- Two Sigma Investments sold 11,229 BioCardia shares in Q1 2026, an estimated $14K.
- Two Sigma Investments first reported a position in BioCardia in Q4 2025 and held it in 1 quarter.
- Two Sigma Investments's BioCardia position peaked at $14K in Q4 2025.
- 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.